// App-Quantinova.ai

AB0736 : SEVERITY OF NAIL PSORIASIS SCORE (SNAPS) IS SENSITIVE TO CHANGE IN A COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH ETANERCEPT

Researchers

Presenter

  • A. Antony

Principal Investigators

  • S. Saeed

  • D. Hart

  • P. Nair

  • C. Cavill

  • E. Korendowych

  • N. Mchugh

  • C. Lovell

  • W. Tillett

Medical Centers

  • Deakin University, Melbourne, Australia

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • University of Bath, Bath, United Kingdom

  • Royal United Hospital Bath, Bath, United Kingdom

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved